nci logo
U.S. National Institutes of Health National Cancer Institute

SEER Inquiry System - Home

Welcome to the SEER Inquiry System (SINQ). SINQ is a collection of questions that cancer registrars have had while coding cancer cases. Click Search to look for specific questions or to select questions for a Report.
Recent Questions 1 to 10 of 1578    Next 10 >    Last >>
Add to Report ID Question Status Last Updated
20120095 MP/H Rules/Multiple primaries--Breast: Regarding rule M6 in the breast MP/H rules, if a patient has a left breast inflammatory carcinoma (ductal with apocrine features on bx), and during work-up, an incidental 1.2 cm lobular carcinoma is discovered in the lateral right breast - localized without any skin involvement - does M6 still apply and this is considered a single primary? The managing physician seems to imply that these are 2 different primaries. However, rule M6 seems to state that inflammatory in either breast makes this a single primary. Final Jan 16 2013
20120094 Reportability: Given that per the 2012 SEER Manual and SINQ 20120081 VIN II-III is no longer reportable, does this also apply to AIN II-III, VAIN II-III, etc.? Or does this change only affect VIN II-III? See discussion. Final Jan 16 2013
20120093 MP/H Rules/Multiple primaries: How many primaries are to be abstracted and what rule applies when a patient has a serous carcinoma of the right ovary treated with neoadjuvant chemotherapy followed by a debulking surgery that also revealed a serous tubal intraepithelial carcinoma of the left fallopian tube? See discussion. Final Dec 14 2012
20120092 MP/H Rules/Multiple Primaries/Recurrence: Can we use the statement of “recurrence” by the pathologist who reviewed all slides to code a single primary if a diagnosis of “squamous cell carcinoma” of the LUL lung is followed three years later by pneumonectomy diagnosis of “adenocarcinoma”? See discussion. Final Jan 16 2013
20120091 Reportability/Behavior--Kidney: Is epithelioid angiomyolipoma (AML) of the kidney a reportable malignancy? See discussion. Final Jan 16 2013
20120090 First course treatment/Chemotherapy: If a specific primary site/histology is listed in SEER*Rx for a given drug, are we only allowed to code that drug as treatment for only those identified Primary Sites/Histologies? See discussion. Final Jan 16 2013
20120089 MP/H Rules/Histology--Colon: The final diagnosis on a path report for a colon specimen says: Carcinoma in situ in a serrated adenoma. Is the correct histology code 8010/2 or 8210/2 or 8213/2? Final Dec 14 2012
20120088 MP/H Rules/Multiple primaries--Head & Neck: How many primaries does this person have and which MP/H rule did you use to determine your answer? See discussion. Final Dec 14 2012
20120087 MP/H Rules/Histology--Kidney: What is the correct code for 'cyst associated renal cell carcinoma', 'cystic renal cell carcinoma', and 'cystic renal cell carcinoma, clear cell type'? See discussion. Final Nov 26 2012
20120086 Primary site--Small intestine: How is primary site coded for a single primary in the deuodenum and the jejunum? See discussion. Final Nov 26 2012
Next 10 >